-
Determining individual glomerular proteinuria and periglomerular infiltration in a cleared murine kidney by a 3D fast-marching algorithm. Kidney Int. (IF 19.6) Pub Date : 2024-03-06 Alexander M.C. Böhner, Alexander Effland, Alice M. Jacob, Karin A.M. Böhner, Zeinab Abdullah, Sebastian Brähler, Ulrike I. Attenberger, Martin Rumpf, Christian Kurts
Three-dimensional imaging has advanced basic research and clinical medicine. However, limited resolution and imperfections of real-world 3D image material often preclude algorithmic image analysis. Here, we present a methodological framework for such imaging and analysis for functional and spatial relations in experimental nephritis. First, optical tissue clearing protocols were optimized to preserve
-
Development of PD in Lower Income Countries: a Rational Solution for the Management of AKI and ESKD Kidney Int. (IF 19.6) Pub Date : 2024-02-29 Brett Cullis, Mignon McCulloch, Fredric O. Finkelstein
It is estimated that more than 50% of patients with end stage kidney disease (ESKD) in low-resource countries are unable to access dialysis. When hemodialysis is available, it often has high out of pocket expenditure and is seldom delivered to the standard recommended by international guidelines. Haemodialysis is a high cost intervention with significant negative effects on environmental sustainability
-
Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies. Kidney Int. (IF 19.6) Pub Date : 2024-02-29 Valentin Maisons, Anna Duval, Laurent Mesnard, Marie Frimat, Fadi Fakhouri, Steven Grangé, Aude Servais, Claire Cartery, Laurent Fauchier, Paul Coppo, Dimitri Titeca-Beauport, Nicolas Fage, Yahsou Delmas, Anne-Hélène Quérard, Guillaume Seret, Mickaël Bobot, Moglie Le Quintrec, Simon Ville, Florent von Tokarski, Sophie Chauvet, Alain Wynckel, Manon Martins, Juliet Schurder, Christelle Barbet, Bénédicte
Thrombotic microangiopathies (TMA) are usually associated with hematological features (RH-TMA). The epidemiology of TMA limited to kidneys (RL-TMA) is unclear Therefore, patients with TMA and native kidney biopsies were identified during 2009-2022 in 20 French hospitals and results evaluated. RL-TMA was present in 341/757 (45%) patients and associated with lower creatinine levels (median 184 vs 346
-
Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney function. Kidney Int. (IF 19.6) Pub Date : 2024-02-29 Evans O. Asowata, Simone Romoli, Rebecca Sargeant, Jennifer Y. Tan, Scott Hoffmann, Margaret M. Huang, Krishnaa T. Mahbubani, Fynn N. Krause, Daniel Jachimowicz, Rasmus Agren, Albert Koulman, Benjamin Jenkins, Barbara Musial, Julian L. Griffin, Magnus Soderberg, Stephanie Ling, Pernille B.L. Hansen, Kourosh Saeb-Parsy, Kevin J. Woollard
Despite the recent advances in our understanding of the role of lipids, metabolites and related enzymes in mediating kidney injury, there is limited integrated multi-omics data identifying potential metabolic pathways driving impaired kidney function. The limited availability of kidney biopsies from living donors with acute kidney injury has remained a major constraint. Here, we validated the use of
-
Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition. Kidney Int. (IF 19.6) Pub Date : 2024-02-29 Jeonghwan Lee, Jinhaeng Lee, Kyuhong Kim, Jiwon Lee, Youngae Jung, Jin Seong Hyeon, Areum Seo, Wencheng Jin, Boram Weon, Nayeon Shin, Sejoong Kim, Chun Soo Lim, Yon Su Kim, Jung Pyo Lee, Geum-Sook Hwang, Seung Hee Yang
Intestinal microbiota and their metabolites affect systemic inflammation and kidney disease outcomes. Here, we investigated the key metabolites associated with the acute kidney injury (AKI)-to chronic kidney disease (CKD) transition and the effect of antibiotic-induced microbiota depletion (AIMD) on this transition. In 61 patients with AKI, 59 plasma metabolites were assessed to determine the risk
-
Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis Kidney Int. (IF 19.6) Pub Date : 2024-02-28 Josep M. Cruzado, Anna Manonelles, Sandra Rayego, Núria Doladé, Ana Amaya-Garrido, Cristian Valera, Roser Guiteras, Jose Luis Mosquera, Michaela Jung, Sergi Codina, Laura Martínez-Valenzuela, Juliana Draibe, Carlos Couceiro, Francesc Vigués, Álvaro Madrid, M. Carolina Florian, Marta Ruíz-Ortega, Anna Sola
Parietal epithelial cells (PECs) are kidney progenitor cells with similarities to a bone marrow stem cell niche. In focal segmental glomerulosclerosis (FSGS) PECs become activated and contribute to extracellular matrix deposition. Colony stimulating factor-1 (CSF-1), a hematopoietic growth factor, acts via its specific receptor, CSF-1R, and has been implicated in several glomerular diseases, although
-
Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury. Kidney Int. (IF 19.6) Pub Date : 2024-02-27 Jianchun Chen, Xiaoyong Wang, Qian He, Hai-Chun Yang, Agnes B. Fogo, Raymond C. Harris
Podocyte injury and loss are hallmarks of diabetic nephropathy (DN). However, the molecular mechanisms underlying these phenomena remain poorly understood. YAP (Yes-associated protein) is an important transcriptional coactivator that binds with various other transcription factors, including the TEAD family members (nuclear effectors of the Hippo pathway), that regulate cell proliferation, differentiation
-
Targeting WIP1 phosphatase promotes partial remission in experimental collapsing glomerulopathy Kidney Int. (IF 19.6) Pub Date : 2024-02-27 Lou C. Duret, Tynhinane Hamidouche, Nicholas J. Steers, Catherine Pons, Nicolas Soubeiran, Delphine Buret, Eric Gilson, Ali G. Gharavi, Vivette D. D’Agati, Marina Shkreli
Collapsing focal segmental glomerulosclerosis (FSGS), also known as collapsing glomerulopathy (CG), is the most aggressive variant of FSGS and is characterized by a rapid progression to kidney failure. Understanding CG pathogenesis represents a key step for the development of targeted therapies. Previous work implicated the telomerase protein component TERT in CG pathogenesis, as transgenic TERT expression
-
A Case-Based Narrative Review of Pregnancy-Associated Atypical Hemolytic Uremic Syndrome/Complement-Mediated Thrombotic Microangiopathy Kidney Int. (IF 19.6) Pub Date : 2024-02-24 Michael Che, Sarah M. Moran, Richard J. Smith, Kevin Y.M. Ren, Graeme N. Smith, M. Khaled Shamseddin, Carmen Avila-Casado, Jocelyn S. Garland
Atypical hemolytic uremic syndrome (aHUS) is a complement-mediated thrombotic microangiopathy (TMA), caused by uncontrolled activation of the alternative complement pathway in the setting of autoantibodies to or rare pathogenic genetic variants in complement proteins. Pregnancy may serve as a trigger and unmask aHUS/complement-mediated TMA [aHUS/CM-TMA] which has severe, life-threatening consequences
-
Quantitative assessment of glomerular basement membrane collagen IV α chains in paraffin sections from patients with focal segmental glomerulosclerosis and Alport gene variants. Kidney Int. (IF 19.6) Pub Date : 2024-02-22 Pongpratch Puapatanakul, Suramath Isaranuwatchai, Ankanee Chanakul, Jerasit Surintrspanont, Kroonpong Iampenkhae, Talerngsak Kanjanabuch, Kanya Suphapeetiporn, Vivek Charu, Hani Y. Suleiman, Kearkiat Praditpornsilpa, Jeffrey H. Miner
Focal segmental glomerulosclerosis (FSGS) lesions have been linked to variants in genes, which are also mutated in Alport syndrome. Although it could be useful for diagnosis, quantitative evaluation of glomerular basement membrane (GBM) type IV collagen (colIV) networks is not widely used to assess these patients. To do so, we developed immunofluorescence imaging for collagen α5(IV) and α1/2(IV) on
-
Disrupting circadian control of autophagy induces podocyte injury and proteinuria Kidney Int. (IF 19.6) Pub Date : 2024-02-21 Lulu Wang, Han Tian, Haiyan Wang, Xiaoming Mao, Jing Luo, Qingyun He, Ping Wen, Hongdi Cao, Li Fang, Yang Zhou, Junwei Yang, Lei Jiang
The circadian clock influences a wide range of biological process and controls numerous aspects of physiology to adapt to the daily environmental changes caused by Earth’s rotation. The kidney clock plays an important role in maintaining tubular function, but its effect on podocytes remains unclear. Here, we found that podocytes expressed CLOCK proteins, and that 2666 glomerular gene transcripts (13
-
The role of desmoglein-2 in kidney disease Kidney Int. (IF 19.6) Pub Date : 2024-02-21 Tong Xu, Lea Herkens, Ting Jia, Barbara M. Klinkhammer, Sebastian Kant, Claudia A. Krusche, Eva M. Buhl, Sikander Hayat, Jürgen Floege, Pavel Strnad, Rafael Kramann, Sonja Djudjaj, Peter Boor
Desmosomes are multi-protein cell-cell adhesion structures supporting cell stability and mechanical stress resilience of tissues; best described in skin and heart. The kidney is exposed to various mechanical stimuli and stress, yet little is known about kidney desmosomes. In healthy kidneys, we found desmosomal proteins located at the apical-junctional complex in tubular epithelial cells. In four different
-
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Jürgen Floege, David R.W. Jayne, Jan-Stephan F. Sanders, Vladimír Tesar, Ethan M. Balk, Craig E. Gordon, Gaelen Adam, Marcello A. Tonelli, Michael Cheung, Amy Earley, Brad H. Rovin
-
Anti-nephrin antibodies in recurrence of focal segmental glomerulosclerosis: closer to discovering the Holy Grail? Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Marina Vivarelli, Manuela Colucci
-
-
The authors reply Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Wenjun Ju, Hiddo J.L. Heerspink, Matthias Kretzler, Petter Bjornstad
-
KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Jürgen Floege, David R.W. Jayne, Jan-Stephan F. Sanders, Vladimír Tesar, Brad H. Rovin
-
-
-
Bile cast nephropathy after sinusoidal obstruction syndrome Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Toshiki Terao, Kyosuke Horikawa, Ken-ichi Matsuoka
-
-
Mind the gap in kidney care: translating what we know into what we do Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Valerie A. Luyckx, Katherine R. Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W.S. Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A. Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, Alessandro Balducci, Vassilios Liakopoulos, Li-Li Hsiao, Ricardo Correa-Rotter, Ifeoma
-
-
Sodium-glucose cotransporter 2 inhibition, epidermal growth factor, and magnesium homeostasis: is there a link? Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Chintan V. Shah
-
-
Sodium-glucose cotransporter 2 inhibitors in the treatment of refractory hypomagnesemia Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Armando Luis Negri
-
Exploring nontraditional cardiorenal advantages of SGLT-2 inhibitors and GLP-1 receptor agonists Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Jia-Jin Chen, Tao-Han Lee, Huang-Yu Yang
-
-
Advancing parathyroid anatomy understanding through single-cell RNA sequencing in uremic secondary hyperparathyroidism Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Iddo Z. Ben-Dov
-
APOL1-mediated and Mendelian forms of “heretofore” idiopathic collapsing glomerulopathy: lessons from Brazil Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Nicholette D. Palmer, Barry I. Freedman
-
A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Cătălin D. Voinescu, Monika Mozere, Giulio Genovese, Mallory L. Downie, Sanjana Gupta, Daniel P. Gale, Detlef Bockenhauer, Robert Kleta, Mauricio Arcos-Burgos, Horia C. Stanescu
Class 2 HLA and PLA2R1 alleles are exceptionally strong genetic risk factors for membranous nephropathy (MN), leading, through an unknown mechanism, to a targeted autoimmune response. Introgressed archaic haplotypes (introduced from an archaic human genome into the modern human genome) might influence phenotypes through gene dysregulation. Here, we investigated the genomic region surrounding the PLA2R1
-
Refining GFR estimation: a quest for the unobservable truth? Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Tariq Shafi
-
-
Mining the amyloid-plaque proteome to uncover disease mechanisms in renal amyloidoses Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Mario Nuvolone, Giampaolo Merlini
-
-
Alternative creatinine-based GFR estimates in United States populations—similar performance, same gaps—is it time to move on? Kidney Int. (IF 19.6) Pub Date : 2024-02-20 June Fabian
-
The Case | A patient with skin rash, monoclonal gammopathy, and proteinuria Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Justyna Fryc, Beata Naumnik
-
-
In remembrance of Eberhard Ritz, MD (1938–2023) Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Kai-Uwe Eckardt, Kerstin Amann
-
Gene editing: a near future for the treatment of genetic kidney diseases Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Fernando Gómez-García, Miguel A. Garcia-Gonzalez
-
Reconstructing the interface between the human intestine and immune system: potential to advance mechanistic studies in IgA nephropathy Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Huamin Wang, James Zuiani, P. Toby Coates AO, Yun Xia
-
Cardiac tamponade diagnosed on nephrologist-performed point-of-care ultrasonography Kidney Int. (IF 19.6) Pub Date : 2024-02-20 Aisha Batool, Abhilash Koratala
-
Reassuring pregnancy outcomes in women with mild COL4A3-5–related disease (Alport Syndrome) and genetic type of disease can aid personalized counseling Kidney Int. (IF 19.6) Pub Date : 2024-02-19 Margriet E. Gosselink MD, Rozemarijn Snoek MD PhD, Agne Cerkauskaite-Kerpauskiene MD PhD, Sophie P.J. van Bakel MD, Renee Vollenberg MD, Henk Groen MD PhD, Rimante Cerkauskiene MD PhD, Marius Miglinas MD PhD, Rossella Attini MD PhD, Kálmán Tory MD PhD, Kathleen Claes MD PhD, Kristel van Calsteren MD PhD, Aude Servais MD PhD, Margriet F.C. de Jong MD PhD, Valentine Gillion MD PhD, Liffert Vogt MD PhD
Individualized pre-pregnancy counseling and antenatal care for women with chronic kidney disease (CKD) require disease-specific data. Here, we investigated pregnancy outcomes and long-term kidney function in women with related disease (Alport Syndrome, (AS)) in a large multicenter cohort. The ALPART-network (mAternaL and fetal PregnAncy outcomes of women with AlpoRT syndrome), an international collaboration
-
An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH). Kidney Int. (IF 19.6) Pub Date : 2024-02-15 Zewu Zhu, Bryan Bo-Ran Ho, Alyssa Chen, James Amrhein, Andreea Apetrei, Thomas Oliver Carpenter, Marise Lazaretti-Castro, Juan Manuel Colazo, Kathryn McCrystal Dahir, Michaela Geßner, Evgenia Gurevich, Cathrine Alsaker Heier, Jill Hickman Simmons, Tracy Earl Hunley, Bernd Hoppe, Christina Jacobsen, Anne Kouri, Nina Ma, Sachin Majumdar, Arnaud Molin, Natalie Nokoff, Susan M. Ott, Helena Gil Peña, Fernando
Pathogenic variants in solute carrier family 34, member 3 (SLC34A3), the gene encoding the sodium-dependent phosphate cotransporter 2c (NPT2c), cause hereditary hypophosphatemic rickets with hypercalciuria (HHRH). Here, we report a pooled analysis of clinical and laboratory records of 304 individuals from 145 kindreds, including 20 previously unreported HHRH kindreds, in which two novel SLC34A3 pathogenic
-
An open label non-inferiority randomized control trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome. Kidney Int. (IF 19.6) Pub Date : 2024-02-13 Aditi Sinha, Kshetrimayum Ghanapriya Devi, Suprita Kalra, Kalaivani Mani, Pankaj Hari, Arvind Bagga
Initial therapies for children with frequently relapsing nephrotic syndrome include alternate-day prednisolone that is given daily during infections, or levamisole. In this open label, non-inferiority trial, 160 patients, 2 to 18-years-old with frequent relapses, were randomly assigned
-
Ibrutinib-associated focal segmental glomerulosclerosis and the impact of podocin mutations in chronic lymphocytic leukemia Kidney Int. (IF 19.6) Pub Date : 2024-02-08 Jan Czogalla, Simon Schliffke, Shun Lu, Maria Schwerk, Helena Petereit, Tianran Zhang, Shuya Liu, Bernhard Dumoulin, Sydney Gies, Guochao Wu, Sonja Hänzelmann, Marlies Bode, Florian Grahammer, Markus Gödel, Minna Voigtländer, Linus Butt, Carsten Bokemeyer, Carsten Bergmann, Thomas Benzing, Thorsten Wiech, Victor G. Puelles, Tobias B. Huber
[Display omitted]
-
Glutamyl-prolyl-tRNA synthetase (EPRS1) drives tubulointerstitial nephritis-induced fibrosis by enhancing T cell proliferation and activity Kidney Int. (IF 19.6) Pub Date : 2024-02-05 Chaelin Kang, Donghwan Yun, Haein Yoon, Minki Hong, Juhyeon Hwang, Hyun Mu Shin, Seokwoo Park, Seongmin Cheon, Dohyun Han, Kyung Chul Moon, Hye Young Kim, Eun Young Choi, Eun-Young Lee, Myung Hee Kim, Chang Wook Jeong, Cheol Kwak, Dong Ki Kim, Kook-Hwan Oh, Kwon Wook Joo, Dong-Sup Lee, Yon Su Kim, Seung Seok Han
-
An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells Kidney Int. (IF 19.6) Pub Date : 2024-02-02 Larissa Seifert, Kristoffer Riecken, Gunther Zahner, Julia Hambach, Julia Hagenstein, Gudrun Dubberke, Tobias B. Huber, Friedrich Koch-Nolte, Boris Fehse, Nicola M. Tomas
[Display omitted]
-
Single-sample measured glomerular filtration rate in Malawi, South Africa, and Uganda Kidney Int. (IF 19.6) Pub Date : 2024-02-01 Sean Currin, Jaya A. George, Christian Holm Hansen, Saraladevi Naicker, Laurie Tomlinson, Amelia Crampin, Robert Kalyesubula, Robert Newton, Wisdom P. Nakanga, Dorothea Nitsch, June Fabian
-
Physiologic Homeostasis after Pig-to-Human Kidney Xenotransplantation Kidney Int. (IF 19.6) Pub Date : 2024-01-28 Eric Judd, Vineeta Kumar, Paige M. Porrett, Kelly A. Hyndman, Douglas Anderson, Maggie Jones-Carr, Andrew Shunk, Daniel R. Epstein, Huma Fatima, Akemi Katsurada, Ryousuke Satou, L. Gabriel Navar, Jayme E. Locke
-
Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine. Kidney Int. (IF 19.6) Pub Date : 2024-01-27 Anna Reznichenko, Viji Nair, Sean Eddy, Damian Fermin, Mark Tomilo, Timothy Slidel, Wenjun Ju, Ian Henry, Shawn S. Badal, Johnna D. Wesley, John T. Liles, Sven Moosmang, Julie M. Williams, Carol Moreno Quinn, Markus Bitzer, Jeffrey B. Hodgin, Laura Barisoni, Anil Karihaloo, Matthew D. Breyer, Kevin L. Duffin, Matthias Kretzler
-
Any reduction in maternal kidney mass makes a difference during pregnancy in gestational and fetal outcome Kidney Int. (IF 19.6) Pub Date : 2024-01-29 Giorgina Barbara Piccoli, Rossella Attini, Massimo Torreggiani, Antoine Chatrenet, Ana Maria Manzione, Bianca Masturzo, Viola Casula, Elisa Longhitano, Eleonora Dalmasso, Luigi Biancone, Antonello Pani, Gianfranca Cabiddu
-
Novel mitophagy inducer alleviates lupus nephritis by reducing myeloid cell activation and autoantigen presentation Kidney Int. (IF 19.6) Pub Date : 2024-01-29 Huijing Wang, Mingdi Shen, Yanhong Ma, Lan Lan, Xue Jiang, Xufeng Cen, Gangqiang Guo, Qin Zhou, Mengmeng Yuan, Jianghua Chen, Hongguang Xia, Liang Xiao, Fei Han
-
Advancements in therapeutic development: kidney organoids and organs on a chip Kidney Int. (IF 19.6) Pub Date : 2024-01-29 Nahid Tabibzadeh, Ryuji Morizane
The use of animal models in therapeutic development has long been the standard practice. However, ethical concerns and the inherent species differences have prompted a reevaluation of the experimental approach in human disease studies. The urgent need for alternative model systems that better mimic human pathophysiology has led to the emergence of organoids, innovative models, to simulate human organs
-
Critical Role of histone deacetylase 3 in the regulation of kidney inflammation and fibrosis Kidney Int. (IF 19.6) Pub Date : 2024-01-28 Yuguo Wang, Baihai Jiao, Zhaoyong Hu, Yanlin Wang
-
Pediatric kidney dimensions and risk of persistent albuminuria in Mexican adolescents Kidney Int. (IF 19.6) Pub Date : 2024-01-25 Mónica Linneth Alcalde-Ortiz, Fernando Jaramillo-Arriaga, Daniel Ibarra-Orenday, Salomón Israel González-Domínguez, Héctor David Calzada-Gallegos, Alma Alejandra Pinales-Jiménez, Itzel Alondra Carrillo-Aguilera, Dimitri Alejandro Flota-Marin, Mariana Guadalupe Collazo-Zamores, Paola Daniela Aguirre-Moreno, Sidharta Denise Gutiérrez-Hernández, Valeria Del Toro-Delgado, Rodolfo Delgadillo-Castañeda,
-
The authors reply Kidney Int. (IF 19.6) Pub Date : 2024-01-18 Anne K. Mühlig, Claus-Peter Schmitt, Jun Oh
Abstract not available
-
Pitfalls in evaluating the impact of persistent hematuria after induction therapy on kidney prognosis in anti-neutrophil cytoplasmic autoantibody–associated vasculitis Kidney Int. (IF 19.6) Pub Date : 2024-01-18 Tomoki Taniguchi, Ryosuke Hiwa, Akio Morinobu
Abstract not available
-
-